53 Investor presentation First three months of 2021 People with obesity are at an incr comorbidities that are life-threate Diabetes Increased risk of type 2 diabetes Only 2% of the 650 million peo treated with prescripti CVD Increased risk of CVD Heart failure Increased risk of heart failure 650 million people with obesity Sleep apnoea Increased severity of sleep apnoea Osteo- arthritis Increased risk of osteoarthritis Visit the doctor Discussion and evaluation of next steps Act ma CVD: Cardiovascular disease; AOM: Anti-obesity medication, TRx SU Volume. The figure illustrates some of the intervention points to treat obesity with prescription medication 1 Attempt to manage weight through lifestyle modification or surgery 2 2% of people with obesity are estimated to be treated with anti-obesity medication Source: World Obesity Federation, 2017
Download PDF file